Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Pharmaceutical

Key Companies in the Lice Treatment Market

Lice infestations can be a persistent and frustrating problem, affecting individuals of all ages. When traditional over-the-counter remedies prove ineffective, many turn to professional lice treatment companies for a more comprehensive and targeted solution.

Report ID: MRFR/Pharma/5668-HCR | Pages: 90 | Author: Kinjoll Dey, Rahul Gotadki | Updated: February 16, 2025
Request Free Sample
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Lice Treatment Market

lice treatment market

Latest Viral Vector Manufacturing Companies Updates:

EndeavorRx by Akili Interactive Labs: This video game-based therapy received FDA approval in October 2023, marking a significant step towards non-pharmacological treatment options for head lice in children aged 8-12.

Xegri by Clarus Therapeutics: This novel topical lotion containing spinosad received FDA approval in July 2023, offering a single-application option with potential advantages like shorter treatment duration and reduced resistance development.

Lice Clinics of America expands services: This leading lice treatment provider announced new offerings like laser lice removal and scalp health treatments, catering to a wider range of customer needs and preferences.

List of Viral Vector Manufacturing  Key companies in the market:

  • Sanofi
  • Topaz Pharmaceuticals Inc
  • GlaxoSmithKline
  • Omega Pharma
  • Pfizer
  • Taro Pharmaceuticals
  • Arbor Pharmaceuticals
  • ICB PHARMA
  • Merck & Co. Inc